Zobrazeno 1 - 10
of 430
pro vyhledávání: '"Su-Jong Yu"'
Autor:
Goh-Eun Chung, Kyungdo Han, Kyu-Na Lee, Eun-Ju Cho, Jung-Ho Bae, Sun-Young Yang, Su-Jong Yu, Seung-Ho Choi, Jeong-Yoon Yim, Nam-Ju Heo
Publikováno v:
Biomedicines, Vol 10, Iss 6, p 1245 (2022)
Background: We investigated the combined effect of chronic kidney disease (CKD) and nonalcoholic fatty liver disease (NAFLD) on the risk of cardiovascular disease (CVD) in patients with type 2 diabetes. Methods: Data were obtained from the Korean Nat
Externí odkaz:
https://doaj.org/article/6bd0b5e4f25e4c5eb6e3a52b8b9cc033
Autor:
Goh-Eun Chung, Young Chang, Yuri Cho, Eun-Ju Cho, Jeong-Ju Yoo, Sang-Hyun Park, Kyungdo Han, Dong-Wook Shin, Su-Jong Yu, Yoon-Jun Kim, Jung-Hwan Yoon
Publikováno v:
Biomedicines, Vol 9, Iss 12, p 1948 (2021)
Background: Nonalcoholic fatty liver disease is considered to be the hepatic component of metabolic syndrome (MetS). However, the association between changes in MetS status and the risk of liver cirrhosis (LC) has not been investigated to date. This
Externí odkaz:
https://doaj.org/article/a772d36e028c49ee9968744d9fcc690c
Autor:
Eun-Ju Cho, Gu-Cheol Jung, Min-Sun Kwak, Jong-In Yang, Jeong-Yoon Yim, Su-Jong Yu, Goh-Eun Chung
Publikováno v:
Diagnostics, Vol 11, Iss 12, p 2233 (2021)
Nonalcoholic fatty liver disease (NAFLD) is increasing worldwide, highlighting the importance of early and accurate detection and the appropriate management of NAFLD. However, ultrasonography (US) is not included in many mass screening programs, and
Externí odkaz:
https://doaj.org/article/ae235b0b203047369ef99d7457d35c23
Publikováno v:
Scientific Reports, Vol 14, Iss 1, Pp 1-11 (2024)
Abstract Metabolic dysfunction-associated steatohepatitis (MASH) is a form of chronic liver inflammation associated with metabolic syndrome, such as obesity and a major cause of hepatocellular carcinoma (HCC). Multi-biotics, a soymilk fermented with
Externí odkaz:
https://doaj.org/article/83b07d903e25454c87f85ae0e42d6b27
Autor:
Eun Ju Cho, Goh Eun Chung, Jeong-Ju Yoo, Yuri Cho, Kyu Na Lee, Dong Wook Shin, Yoon Jun Kim, Jung-Hwan Yoon, Kyungdo Han, Su Jong Yu
Publikováno v:
Cardiovascular Diabetology, Vol 23, Iss 1, Pp 1-9 (2024)
Abstract Background The association between nonalcoholic fatty liver disease (NAFLD) and atrial fibrillation (AF) has been inconsistent, and the impact of hepatic fibrosis on this relationship remains uncertain. We investigated the association betwee
Externí odkaz:
https://doaj.org/article/f16c3cc847214aa399c230a7c445bfde
Publikováno v:
BMC Gastroenterology, Vol 24, Iss 1, Pp 1-9 (2024)
Abstract Radiofrequency ablation (RFA) offers a minimally invasive treatment for small hepatocellular carcinoma (HCC), but it faces challenges such as high local recurrence rates. This prospective study, conducted from January 2020 to July 2022, eval
Externí odkaz:
https://doaj.org/article/c5856f36efe04167b6ab5883ffcd5087
Autor:
Moon Haeng Hur, Dong Hyeon Lee, Jeong-Hoon Lee, Mi-Sook Kim, Jeayeon Park, Hyunjae Shin, Sung Won Chung, Hee Jin Cho, Min Kyung Park, Heejoon Jang, Yun Bin Lee, Su Jong Yu, Sang Hyub Lee, Yong Jin Jung, Yoon Jun Kim, Jung-Hwan Yoon
Publikováno v:
Clinical and Molecular Hepatology, Vol 30, Iss 3, Pp 500-514 (2024)
Background/Aims Chronic hepatitis B (CHB) is related to an increased risk of extrahepatic malignancy (EHM), and antiviral treatment is associated with an incidence of EHM comparable to controls. We compared the risks of EHM and intrahepatic malignanc
Externí odkaz:
https://doaj.org/article/3b0ba119aada4a9780611141036671ff
Autor:
Jeayeon Park, Yun Bin Lee, Yunmi Ko, Youngsu Park, Hyunjae Shin, Moon Haeng Hur, Min Kyung Park, Dae-Won Lee, Eun Ju Cho, Kyung-Hun Lee, Jeong-Hoon Lee, Su Jong Yu, Tae-Yong Kim, Yoon Jun Kim, Tae-You Kim, Jung-Hwan Yoon
Publikováno v:
Journal of Liver Cancer, Vol 24, Iss 1, Pp 81-91 (2024)
Background/Aim Atezolizumab plus bevacizumab and lenvatinib are currently available as first-line therapy for the treatment of unresectable hepatocellular carcinoma (HCC). However, comparative efficacy studies are still limited. This study aimed to i
Externí odkaz:
https://doaj.org/article/0fba6f18253441e3be10280165c026e9
Autor:
Kyung Hwa Lee, Gwang Hyeon Choi, Jihye Yun, Jonggi Choi, Myung Ji Goh, Dong Hyun Sinn, Young Joo Jin, Minseok Albert Kim, Su Jong Yu, Sangmi Jang, Soon Kyu Lee, Jeong Won Jang, Jae Seung Lee, Do Young Kim, Young Youn Cho, Hyung Joon Kim, Sehwa Kim, Ji Hoon Kim, Namkug Kim, Kang Mo Kim
Publikováno v:
npj Digital Medicine, Vol 7, Iss 1, Pp 1-8 (2024)
Abstract The treatment decisions for patients with hepatocellular carcinoma are determined by a wide range of factors, and there is a significant difference between the recommendations of widely used staging systems and the actual initial treatment c
Externí odkaz:
https://doaj.org/article/db78a9799bd04ddca825268850366cd4
Autor:
Young Chang, Su Jong Yu, Hyo-Cheol Kim, Yun Bin Lee, Eun Ju Cho, Jeong-Hoon Lee, Yoon Jun Kim, Jin Wook Chung, Jung-Hwan Yoon
Publikováno v:
Gut and Liver, Vol 18, Iss 1, Pp 156-164 (2024)
Background/Aims: This study aimed to assess whether hepatocellular carcinoma (HCC) patients with portal vein tumor thrombosis (PVTT) could have favorable prognoses with proper treatment under selective conditions. Methods: This retrospective, single-
Externí odkaz:
https://doaj.org/article/4ef2a46547114d2e9815ca41a3a1fcdd